Prevalence of anogenital HPV infection, related disease and risk factors among HIV-infected men in inner-city Johannesburg, South Africa: baseline findings from a cohort study

Table 3 The socio-behavioural, clinical and HIV-related factors associated with anogenital warts

Characteristic	AGW detected N = 36 n (%) or mean (SD)	M 1 (Crude) OR (95% CI)	p-value	M2 ^a OR (95%CI)	p-value
Born in SA	27 (75)	1.44 (0.65–3.20)	0.36	1.60 (0.71–3.58)	0.25
Marital status (Single)	29 (80)	2.00 (0.83–4.81)	0.12	1.71 (0.69–4.21)	0.24
Employed	26 (72)	1.20 (0.54–2.67)	0.66	1.02 (0.45–2.30)	0.97
Currently smokes	12 (33)	1.13 (0.54–2.38)	0.74	1.16 (0.55–2.44)	0.70
Currently drinks alcohol	20 (56)	1.18 (0.58–2.41)	0.65	1.09 (0.53–2.24)	0.82
Age at sexual debut	18 (3)	0.99 (0.89–1.11)	0.91	1.00 (0.89–1.13)	0.93
Ever had sex with men	1 (3)	0.52 (0.07–4.06)	0.53	0.48 (0.06–3.80)	0.49
> 1 sexual partners in past 3 months	8 (22)	0.89 (0.38–2.04)	0.78	0.82 (0.35–1.92)	0.65
Consistent condom use with recent partner	25 (69)	1.81 (0.52–6.31)	0.35	2.16 (0.61–7.70)	0.23
Circumcised	3 (8)	0.32 (0.10–1.09)	0.06	0.33 (0.09–1.13)	0.07
On ART	26 (72)	1.47 (0.68–3.19)	0.32	2.19 (0.94–5.07)	0.07
Duration on ART (months)
> 12	14 (39)	1		1
6–12	8 (22)	4.03 (1.50–10.81)	0.006	3.54 (1.29–9.72)	0.01
< 6	4 (11)	8.06 (1.94–33.50)	0.004	6.90 (1.63–29.20)	0.009
CD4+ count (cells/μL)
> 500	7 (19)	1		1
351–500	10 (28)	1.72 (0.63–4.71)	0.29	1.62 (0.58–4.49)	0.93
200–350	12 (33)	3.68 (1.36–9.95)	0.01	4.34 (1.57–12.07)	0.01
< 200	6 (17)	4.32 (1.32–14.25)	0.02	5.48 (1.60–18.78)	0.01
Undetectable PVL (<40 copies/ml)	11 (31)	0.65 (0.31–1.39)	0.26	0.77 (0.35–1.68)	0.51
Controlled HIV disease^b	3 (8)	0.25 (0.08–0.85)	0.03	0.22 (0.12–0.79)	0.02
Cytological abnormalities	10 (28)	0.67 (0.29–1.55)	0.35	0.67 (0.29–1.59)	0.37

M2^a: Adjusted for age. PVL plasma viral load. ^b: On ART for >6 months, CD4+ > 350 and undetectable PVL

ISSN: 1471-2458